Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 1,241 | 567 | 779 | 928 | 758 |
| Cost of Goods | 123 | 114 | 107 | 68 | 52 |
| Gross Profit | 1,118 | 453 | 672 | 860 | 706 |
| Operating Expenses | 8,113 | 8,989 | 11,600 | 13,689 | 10,865 |
| Operating Income | -6,872 | -8,422 | -10,821 | -12,761 | -10,107 |
| Interest Expense | 0 | 0 | 0 | -442 | -537 |
| Other Income | 1,532 | -9,084 | -20,479 | 47,231 | -35,760 |
| Pre-tax Income | -5,340 | -17,506 | -31,300 | 34,912 | -45,330 |
| Income Tax | -784 | -991 | -1,248 | -4,384 | N/A |
| Net Income Continuous | -4,556 | -16,515 | -30,052 | 39,296 | -44,984 |
| Minority Interests | -74 | -10 | -20 | -14 | -32 |
| Net Income | $-4,482 | $-16,505 | $-30,032 | $39,310 | $-44,952 |
| EPS Basic Total Ops | -0.07 | -0.11 | -0.20 | 0.30 | -0.36 |
| EPS Basic Continuous Ops | -0.07 | -0.11 | -0.20 | 0.30 | -0.35 |
| EPS Diluted Total Ops | -0.07 | -0.11 | -0.20 | 0.30 | -0.36 |
| EPS Diluted Continuous Ops | -0.07 | -0.11 | -0.20 | 0.30 | -0.35 |
| EBITDA(a) | $-6,068 | $-7,629 | $-10,057 | $-11,993 | $-9,363 |